A Multi-center, Randomized, Double-blind, Double Dummy, Placebo and Active Controlled Crossover Study, to Investigate the 24 Hour FEV1 Profile of a Single Dose of QMF TWISTHALER Device in Adult Patients With Persistent Asthma using fluticasone propionate/salmeterol (250/50 μg b.i.d.) as an active control.
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2014
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 11 Oct 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2007-003192-39)
- 20 Mar 2013 Actual end date changed from Jun 2008 to Apr 2008 as reported by ClinicalTrials.gov.
- 08 Apr 2009 Actual patient number (37) added as reported by ClinicalTrials.gov.